• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

群体药代动力学建模中的分形动力学实现

Fractal Kinetic Implementation in Population Pharmacokinetic Modeling.

作者信息

Jung Woojin, Ryu Hyo-Jeong, Chae Jung-Woo, Yun Hwi-Yeol

机构信息

College of Pharmacy, Chungnam National University, Daejeon 34134, Republic of Korea.

Department of Bio-AI Convergence, Chungnam National University, Daejeon 34134, Republic of Korea.

出版信息

Pharmaceutics. 2023 Jan 16;15(1):304. doi: 10.3390/pharmaceutics15010304.

DOI:10.3390/pharmaceutics15010304
PMID:36678932
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9867137/
Abstract

Compartment modeling is a widely accepted technique in the field of pharmacokinetic analysis. However, conventional compartment modeling is performed under a homogeneity assumption that is not a naturally occurring condition. Since the assumption lacks physiological considerations, the respective modeling approach has been questioned, as novel drugs are increasingly characterized by physiological or physical features. Alternative approaches have focused on fractal kinetics, but evaluations of their application are lacking. Thus, in this study, a simulation was performed to identify desirable fractal-kinetics applications in conventional modeling. Visible changes in the profiles were then investigated. Five cases of finalized population models were collected for implementation. For model diagnosis, the objective function value (OFV), Akaike's information criterion (AIC), and corrected Akaike's information criterion (AICc) were used as performance metrics, and the goodness of fit (GOF), visual predictive check (VPC), and normalized prediction distribution error (NPDE) were used as visual diagnostics. In most cases, model performance was enhanced by the fractal rate, as shown in a simulation study. The necessary parameters of the fractal rate in the model varied and were successfully estimated between 0 and 1. GOF, VPC, and NPDE diagnostics show that models with the fractal rate described the data well and were robust. In the simulation study, the fractal absorption process was, therefore, chosen for testing. In the estimation study, the rate application yielded improved performance and good prediction-observation agreement in early sampling points, and did not cause a large shift in the original estimation results. Thus, the fractal rate yielded explainable parameters by setting only the heterogeneity exponent, which reflects true physiological behavior well. This approach can be expected to provide useful insights in pharmacological decision making.

摘要

房室模型是药代动力学分析领域中一种广泛接受的技术。然而,传统的房室模型是在一个并非自然存在的均一性假设下进行的。由于该假设缺乏生理学考量,随着新型药物越来越多地具有生理学或物理特征,相应的建模方法受到了质疑。替代方法聚焦于分形动力学,但对其应用的评估却很缺乏。因此,在本研究中,进行了一项模拟以确定传统建模中理想的分形动力学应用。然后研究了曲线中的可见变化。收集了五个最终确定的群体模型用于实施。对于模型诊断,目标函数值(OFV)、赤池信息准则(AIC)和校正赤池信息准则(AICc)被用作性能指标,而拟合优度(GOF)、可视化预测检验(VPC)和标准化预测分布误差(NPDE)被用作可视化诊断方法。在大多数情况下,如模拟研究所示,分形速率提高了模型性能。模型中,分形速率的必要参数各不相同,且成功估计值在0到1之间。GOF、VPC和NPDE诊断表明,具有分形速率的模型能很好地描述数据且具有稳健性。因此,在模拟研究中选择了分形吸收过程进行测试。在估计研究中,速率应用在早期采样点提高了性能并达成了良好的预测 - 观测一致性,且未导致原始估计结果出现大幅偏移。这样,通过仅设置反映真实生理行为的异质性指数,分形速率就能产生可解释的参数。这种方法有望在药理决策中提供有用的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f381/9867137/3c7d4aee67d3/pharmaceutics-15-00304-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f381/9867137/6c6eec225458/pharmaceutics-15-00304-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f381/9867137/8c3447eda132/pharmaceutics-15-00304-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f381/9867137/4fb975a47a2e/pharmaceutics-15-00304-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f381/9867137/84a3616f3c40/pharmaceutics-15-00304-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f381/9867137/cef700736172/pharmaceutics-15-00304-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f381/9867137/3c7d4aee67d3/pharmaceutics-15-00304-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f381/9867137/6c6eec225458/pharmaceutics-15-00304-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f381/9867137/8c3447eda132/pharmaceutics-15-00304-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f381/9867137/4fb975a47a2e/pharmaceutics-15-00304-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f381/9867137/84a3616f3c40/pharmaceutics-15-00304-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f381/9867137/cef700736172/pharmaceutics-15-00304-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f381/9867137/3c7d4aee67d3/pharmaceutics-15-00304-g006.jpg

相似文献

1
Fractal Kinetic Implementation in Population Pharmacokinetic Modeling.群体药代动力学建模中的分形动力学实现
Pharmaceutics. 2023 Jan 16;15(1):304. doi: 10.3390/pharmaceutics15010304.
2
Using Akaike's information theoretic criterion in mixed-effects modeling of pharmacokinetic data: a simulation study.在药代动力学数据的混合效应建模中使用赤池信息理论准则:一项模拟研究。
F1000Res. 2013 Mar 4;2:71. doi: 10.12688/f1000research.2-71.v2. eCollection 2013.
3
Fractal pharmacokinetics.分形药物动力学
Comput Math Methods Med. 2010 Jun;11(2):161-84. doi: 10.1080/17486700903029280.
4
[Comparison study of model evaluation methods: normalized prediction distribution errors vs. visual predictive check].模型评估方法的比较研究:标准化预测分布误差与可视化预测检查
Yao Xue Xue Bao. 2011 Sep;46(9):1123-31.
5
Standardized visual predictive check versus visual predictive check for model evaluation.标准化视觉预测检查与模型评估的视觉预测检查。
J Clin Pharmacol. 2012 Jan;52(1):39-54. doi: 10.1177/0091270010390040. Epub 2011 Jan 21.
6
Pharmacokinetic/Pharmacodynamic Analysis of Metformin using Different Models in Diabetic Rats.使用不同模型对糖尿病大鼠进行二甲双胍的药代动力学/药效学分析。
Drug Res (Stuttg). 2016 Oct;66(10):547-554. doi: 10.1055/s-0042-111514. Epub 2016 Jul 27.
7
Population pharmacokinetics and dose simulation of oxcarbazepine in Chinese paediatric patients with epilepsy.奥卡西平在中国癫痫患儿中的群体药代动力学及剂量模拟
J Clin Pharm Ther. 2019 Apr;44(2):300-311. doi: 10.1111/jcpt.12792. Epub 2019 Jan 12.
8
Simultaneous optimization of limited sampling points for pharmacokinetic analysis of amrubicin and amrubicinol in cancer patients.癌症患者中氨柔比星和氨柔比星醇药代动力学分析有限采样点的同时优化
Asia Pac J Clin Oncol. 2016 Sep;12(3):259-64. doi: 10.1111/ajco.12485. Epub 2016 Mar 7.
9
Evaluation of different tests based on observations for external model evaluation of population analyses.基于观察的不同检验方法在群体分析外部模型评价中的评估。
J Pharmacokinet Pharmacodyn. 2010 Feb;37(1):49-65. doi: 10.1007/s10928-009-9143-7. Epub 2009 Dec 23.
10
Pharmacokinetic analysis of tissue microcirculation using nested models: multimodel inference and parameter identifiability.使用嵌套模型进行组织微循环的药代动力学分析:多模型推断与参数可识别性
Med Phys. 2009 Jul;36(7):2923-33. doi: 10.1118/1.3147145.

本文引用的文献

1
Model-Based Equivalent Dose Optimization to Develop New Donepezil Patch Formulation.基于模型的等效剂量优化以开发新的多奈哌齐贴剂制剂
Pharmaceutics. 2022 Jan 20;14(2):244. doi: 10.3390/pharmaceutics14020244.
2
Tailored Pharmacokinetic model to predict drug trapping in long-term anesthesia.定制药代动力学模型预测长期麻醉中的药物滞留。
J Adv Res. 2021 May 21;32:27-36. doi: 10.1016/j.jare.2021.04.004. eCollection 2021 Sep.
3
Development of a Pharmacokinetic Model Describing Neonatal Fc Receptor-Mediated Recycling of HL2351, a Novel Hybrid Fc-Fused Interleukin-1 Receptor Antagonist, to Optimize Dosage Regimen.
开发描述新型 Fc-融合型白细胞介素-1 受体拮抗剂 HL2351 经新生儿 Fc 受体介导的再循环的药代动力学模型,以优化剂量方案。
CPT Pharmacometrics Syst Pharmacol. 2020 Oct;9(10):584-595. doi: 10.1002/psp4.12555. Epub 2020 Oct 6.
4
Saddle-Reset for Robust Parameter Estimation and Identifiability Analysis of Nonlinear Mixed Effects Models.鞍点重置法在非线性混合效应模型的稳健参数估计和可识别性分析中的应用。
AAPS J. 2020 Jul 2;22(4):90. doi: 10.1208/s12248-020-00471-y.
5
A Tutorial on RxODE: Simulating Differential Equation Pharmacometric Models in R.RxODE教程:在R中模拟微分方程药物计量学模型
CPT Pharmacometrics Syst Pharmacol. 2016 Jan;5(1):3-10. doi: 10.1002/psp4.12052. Epub 2015 Dec 19.
6
Using Akaike's information theoretic criterion in mixed-effects modeling of pharmacokinetic data: a simulation study.在药代动力学数据的混合效应建模中使用赤池信息理论准则:一项模拟研究。
F1000Res. 2013 Mar 4;2:71. doi: 10.12688/f1000research.2-71.v2. eCollection 2013.
7
Basic concepts in population modeling, simulation, and model-based drug development-part 2: introduction to pharmacokinetic modeling methods.群体建模、模拟及基于模型的药物研发基础概念——第2部分:药代动力学建模方法介绍
CPT Pharmacometrics Syst Pharmacol. 2013 Apr 17;2(4):e38. doi: 10.1038/psp.2013.14.
8
Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models.用于诊断非线性混合效应模型的预测校正可视化预测检验。
AAPS J. 2011 Jun;13(2):143-51. doi: 10.1208/s12248-011-9255-z. Epub 2011 Feb 8.
9
Fractional kinetics in multi-compartmental systems.多室系统中的分数动力学。
J Pharmacokinet Pharmacodyn. 2010 Oct;37(5):507-24. doi: 10.1007/s10928-010-9170-4. Epub 2010 Oct 1.
10
Power law IVIVC: an application of fractional kinetics for drug release and absorption.幂律 IVIVC:药物释放和吸收的分数动力学应用。
Eur J Pharm Sci. 2010 Oct 9;41(2):299-304. doi: 10.1016/j.ejps.2010.06.015. Epub 2010 Jul 3.